Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration

被引:35
|
作者
Imfeld-Isenegger, Tamara Leila [1 ]
Soares, Ines Branco [2 ]
Makovec, Urska Nabergoj [3 ]
Horvat, Nejc [3 ]
Kos, Mitja [3 ]
van Mil, Foppe [4 ]
Costa, Filipa A. [2 ]
Hersberger, Kurt E. [1 ]
机构
[1] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[2] IUEM, CiiEM, Campus Univ, P-2829511 Monte De Caparica, Caparica, Portugal
[3] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[4] Von Mil Consultancy, Margrietlaan 1, NL-9471 CT Zuidlaren, Netherlands
来源
关键词
Medication review; Community pharmacy services; Primary health care; Service implementation; Remuneration; Europe; DRUG-RELATED PROBLEMS; FOLLOW-UP SERVICE; PHARMACEUTICAL CARE; THERAPY MANAGEMENT; POLYPHARMACY; TERMINOLOGY; ELIGIBILITY;
D O I
10.1016/j.sapharm.2019.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking. Objective: The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe. Methods: An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses. Results: Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate = 77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history + patient interview) in 14, type 2b (medication history + clinical data) in two, and type 3 medication review (medication history + patient interview + clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party. Conclusion: Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
引用
收藏
页码:1057 / 1066
页数:10
相关论文
共 50 条
  • [41] The effectiveness of pharmacist-led medication reviews in people living with dementia: a systematic review
    Orakwe, C.
    Mckenzie, C.
    Jones, S.
    Van Wamelen, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 658 - 658
  • [42] Pharmacist-led biometric screenings: A retrospective chart review in a community pharmacy
    Brown, Stephen A.
    Wensel, Terri M.
    Smith, Wyatt
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2024, 20 (02): : 145 - 148
  • [43] Implementation of a Pharmacist-Led Diabetes Management Protocol
    Al-Omar, Lana T.
    Anderson, Sarah L.
    Cizmic, Amber D.
    Vlasimsky, Tara B.
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (01): : 14 - 19
  • [44] Pharmacist-led medication reviews in aged care residents with dementia: A systematic review
    McDerby, Nicole
    Kosari, Sam
    Bail, Kasia
    Shield, Alison
    Peterson, Greg
    Naunton, Mark
    AUSTRALASIAN JOURNAL ON AGEING, 2020, 39 (04) : E478 - E489
  • [46] Impact of pharmacist-led medication management in care transitions
    Yang, Seungwon
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [47] Pharmacist-led medication reconciliation in emergency hospital services in Brazil: A scoping review
    Milanez-Azevedo, Mayara
    Zago-Oliveira, Thalita
    Alves-Reis, Debora
    Leira-Pereira, Leonardo Regis
    Rossi-Varallo, Fabiana
    FARMACIA HOSPITALARIA, 2022, 46 (04) : 234 - 243
  • [48] Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial
    Messerli, Markus
    Blozik, Eva
    Vriends, Noortje
    Hersberger, Kurt E.
    BMC HEALTH SERVICES RESEARCH, 2016, 16 : 145
  • [49] Evaluation of human immunodeficiency virus medication errors in a community hospital following the implementation of a pharmacist-led antiretroviral stewardship program
    Bunn, Haden T. T.
    Hester, E. Kelly
    Maldonado, Ricardo A. A.
    Childress, Darrell
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (03): : 593 - 600
  • [50] Pharmacist-led medicine use review in community pharmacy for patients on warfarin
    Mifsud, Elena M.
    Wirth, Francesca
    Camilleri, Liberato
    Azzopardi, Lilian M.
    Serracino-Inglott, Anthony
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (03) : 741 - 750